Bladder cancer is the second most common cancer in males and the third most common in the Egyptian population with more than 13 thousand newly diagnosed cases. ⁽¹⁾ Moreover, it is also the third cause of cancer death in Egypt after hepatocellular carcinoma and breast cancer with estimated number of more than 7 thousand deaths in 2022.

➡️Purpose and scope

These guidelines will help to improve the quality of care for both NMIBL and MIBC patients via providing a uniform standard of care across the country to help in early diagnosis and treatment for bladder cancer, with less aggressive treatment options and improved clinical outcomes. These guidelines cover primary diagnosis, staging, treatment and follow-up of bladder cancer patients.